首页 | 本学科首页   官方微博 | 高级检索  
检索        

奥沙利铂联合卡培他滨方案治疗老年晚期胃癌的临床观察
引用本文:傅聿铭,张自森,薛长年,吴敏.奥沙利铂联合卡培他滨方案治疗老年晚期胃癌的临床观察[J].医药论坛杂志,2011(15):3-5.
作者姓名:傅聿铭  张自森  薛长年  吴敏
作者单位:郑州大学第五附属医院;
基金项目:河南省医学科技攻关基金资助项目(200804044)
摘    要:目的观察奥沙利铂联合卡培他滨方案治疗晚期胃癌的临床疗效及不良反应。方法 34例晚期老年胃癌患者,给予XELOX方案化疗,每21d为1周期,至少完成2个周期。评价客观疗效和不良反应。结果全组34例均可评价疗效,其中PR 14(41.2%),SD 10例(29.4%),PD 10例(29.4%)。中位肿瘤进展时间为5.2个月。化疗前ECOG评分与TTP显著相关。不良反应主要是骨髓抑制,胃肠道反应及外周神经毒性。结论奥沙利铂联合卡培他滨方案是治疗老年性晚期胃癌的有效方案,尤其适用于体力状况较好的患者。

关 键 词:奥沙利铂  卡培他滨  晚期胃癌  化疗

Clinical observation on older patients with advanced gastric cancer treated with oxaliplatin plus capecitabine
FU Yu-ming,ZHANG Zi-sen,XUE Chang-yan,WU Min.Clinical observation on older patients with advanced gastric cancer treated with oxaliplatin plus capecitabine[J].Journal of Medical Forum,2011(15):3-5.
Authors:FU Yu-ming  ZHANG Zi-sen  XUE Chang-yan  WU Min
Institution:FU Yu-ming,ZHANG Zi-sen,XUE Chang-yan,WU MinDepartment of general surgery,the Fifth Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China
Abstract:Objective To evaluate the efficacy and toxicity of oxaliplatin plus capecitabine(XELOX) in the treatment of advanced gastric cancer.Methods Totally thirty-four patients with advanced gastric cancer were treated with chemotherapy of XELOX regimen,21days for one cycle.All patients received at least two cycles of chemotherapy.Efficacy and toxicity were evaluated.Results All the 34 patients were evaluated.There were fourteen cases of objective response(PR,41.2%),10 cases of SD(29.4%)and 10 cases of PD(29.4%).Th...
Keywords:Oxaliplatin  Capecitabine  Advanced gastric cancer  Chemotherapy  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号